Bank of New York Mellon Corp Trims Stake in Agilent Technologies, Inc. $A

Bank of New York Mellon Corp cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,012,132 shares of the medical research company’s stock after selling 75,746 shares during the quarter. Bank of New York Mellon Corp owned about 0.71% of Agilent Technologies worth $258,257,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Forum Financial Management LP increased its position in shares of Agilent Technologies by 2.5% during the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock valued at $375,000 after acquiring an additional 70 shares during the last quarter. Wedmont Private Capital boosted its position in shares of Agilent Technologies by 2.3% during the 3rd quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock worth $503,000 after purchasing an additional 81 shares during the period. waypoint wealth counsel increased its holdings in Agilent Technologies by 4.3% in the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock valued at $255,000 after purchasing an additional 82 shares during the last quarter. Verdence Capital Advisors LLC raised its position in Agilent Technologies by 5.0% in the second quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock valued at $215,000 after purchasing an additional 86 shares during the period. Finally, M&T Bank Corp lifted its stake in Agilent Technologies by 0.4% during the second quarter. M&T Bank Corp now owns 23,205 shares of the medical research company’s stock worth $2,738,000 after purchasing an additional 86 shares in the last quarter.

Agilent Technologies Trading Down 0.5%

Shares of NYSE:A opened at $133.20 on Friday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The company’s 50 day moving average is $142.57 and its two-hundred day moving average is $134.30. The company has a market cap of $37.76 billion, a PE ratio of 29.15, a P/E/G ratio of 3.89 and a beta of 1.29. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter in the prior year, the company posted $1.46 earnings per share. Agilent Technologies’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were paid a dividend of $0.255 per share. The ex-dividend date was Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on A shares. HSBC began coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective for the company. Hsbc Global Res upgraded shares of Agilent Technologies to a “strong-buy” rating in a research note on Tuesday, January 20th. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price target on the stock. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $164.50.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. This represents a 27.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,401 shares of company stock valued at $2,468,962 over the last ninety days.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.